The protein Fam204a, also known as Family With Sequence Similarity 204, Member A, is encoded by the FAM204A gene . GeneCards provides information regarding the function, localization, and complex membership of the protein . Studies on FAM204A have shown its involvement in various cellular processes and its potential association with certain diseases .
FAM204A is a mitochondrial protein crucial for regulating cytosolic protein translation in skeletal muscle cells . The expression level of FAM204A is positively correlated with muscle mass in both mice and humans .
Fam210a knockout in mice reduces mitochondrial density and function, leading to muscle atrophy and premature death . Metabolomic analyses indicate that Fam210a knockout reverses the oxidative TCA cycle, causing acetyl-CoA accumulation and hyperacetylation of cytosolic proteins, which leads to translational defects . Studies show that FAM210A protein levels are lower in models of human Duchenne muscular dystrophy (DMD), while mRNA expression is elevated in hypertrophic muscles, suggesting its role in muscle maintenance and growth .
Experiments using a muscle-specific Myl1/Cre Fam210a knockout mouse model have demonstrated the importance of FAM204A in muscle health . These knockout mice exhibit stunted growth, reduced muscle size, and metabolic defects . Deletion of Fam210a disrupts mitochondrial structure and reduces mitochondrial abundance in myofibers, impairing mitochondrial energy metabolism .
Mouse FAM204A (Family with sequence similarity 204 member A) is encoded by the Fam204a gene, also known by synonyms 2310065H12Rik, 2610015K05Rik, and D19Ertd737e. The gene has multiple transcript variants documented in RefSeq (NM_029648, NM_001358271, NM_001358272, NM_001358273, NR_152390, NR_152391). The protein has a UniProt ID of Q8C6C7 and a Locus ID of 76539 .
FAM204A belongs to a protein family characterized by the InterPro domain IPR037690. The zebrafish ortholog (fam204a) has been classified as a protein-coding gene located on chromosome 13, further supporting evolutionary conservation of this gene family .
Based on available data, mouse FAM204A contains the InterPro domain IPR037690 (Protein FAM204A family). The zebrafish ortholog indicates a protein length of 234 amino acids . While direct structural information about mouse FAM204A is limited in current literature, analysis of related FAM proteins suggests potential features.
Current literature provides limited direct evidence about FAM204A tissue-specific expression patterns. For researchers investigating expression patterns, recommended approaches include:
RT-qPCR analysis across multiple tissue types and developmental stages
Western blot analysis using validated antibodies
RNA-seq data mining from public databases
In situ hybridization for spatial expression analysis
Related FAM proteins show tissue-specific expression patterns – for example, FAM208A (D14Abb1e) shows strong expression in skin, brain, and testis , while FAM20 family members show differential expression during hematopoietic differentiation . Similar methodologies could be applied to characterize FAM204A expression.
For researchers aiming to detect endogenous FAM204A, a multi-method approach is recommended:
| Method | Application | Considerations |
|---|---|---|
| Western blotting | Protein expression quantification | Validate antibody specificity with knockdown controls |
| Immunohistochemistry | Tissue localization | Optimize fixation protocols for epitope preservation |
| RT-qPCR | Transcript level analysis | Design primers spanning exon junctions to avoid genomic DNA |
| Mass spectrometry | Protein identification confirmation | Useful for antibody validation and PTM analysis |
When selecting antibodies, researchers should verify specificity through appropriate controls such as knockdown validation, as demonstrated with FAM208A detection where siRNA treatment confirmed antibody specificity .
Current tools for genetic manipulation of Fam204a include:
CRISPR activation (CRISPRa) technology for upregulating endogenous Fam204a expression. Commercial kits include three gRNA vectors targeting Fam204a, a CRISPRa-Enhancer vector, and appropriate controls .
CRISPR knockout systems employing non-homology mediated gene editing, enabling loss-of-function studies .
When designing genetic manipulation experiments, researchers should consider:
Cell-type specific effects of FAM204A modulation
Potential compensatory mechanisms by related genes
Phenotypic analysis at multiple levels (molecular, cellular, physiological)
Appropriate control conditions (scrambled gRNAs, empty vectors)
The efficacy of CRISPR-based activation can be affected by factors including "nucleosome occupancy status, chromatin structure and gene expression level of the target" , requiring optimization for specific experimental systems.
While the literature doesn't provide specific optimization parameters for FAM204A expression, researchers can apply established approaches based on predicted protein characteristics:
| Expression System | Advantages | Limitations | Recommended Applications |
|---|---|---|---|
| E. coli | High yield, cost-effective | Limited PTMs, potential folding issues | Initial structural studies, antibody production |
| Mammalian (HEK293/CHO) | Native-like PTMs, proper folding | Higher cost, lower yield | Functional studies, interaction analyses |
| Insect cells (Sf9/Sf21) | Higher yield than mammalian, some PTMs | Glycosylation differs from mammalian | Compromise between yield and functionality |
| Cell-free systems | Rapid production, toxic protein expression | Limited PTMs, lower yield | Initial screening, pilot studies |
Expression system selection should be guided by:
Predicted post-translational modifications
Experimental application requirements
Scale of protein production needed
Budget and time constraints
To determine FAM204A function, researchers could employ these methodological approaches:
Subcellular localization studies using fluorescent protein fusions or immunolocalization
Interactome analysis using techniques such as:
Affinity purification followed by mass spectrometry
Yeast two-hybrid screening
Proximity labeling (BioID, APEX)
Phenotypic analysis following genetic perturbation:
Proliferation and cell cycle analysis
Differentiation capacity assessment
Transcriptomic changes via RNA-seq
For context, related FAM protein studies have yielded functional insights - FAM208A interacts with H3K9me3 (a chromatin mark associated with gene silencing) , and FAM20 family members play roles in regulating differentiation and function of hematopoietic tissues .
Developmental biology approaches to study FAM204A might include:
Temporal expression analysis during embryonic development
Conditional knockout models using tissue-specific or temporally regulated Cre lines
Chimeric embryo analysis using FAM204A-deficient ES cells
In vitro differentiation models using embryonic stem cells or induced pluripotent stem cells
When interpreting developmental phenotypes, lessons from related FAM proteins are instructive. For example, homozygous mutations in D14Abb1e (FAM208A) resulted in embryonic lethality beyond gastrulation, demonstrating its essential role in development . Analysis of heterozygous animals revealed effects on transgene expression at the RNA level, suggesting dosage sensitivity .
To investigate potential gene regulatory functions, researchers might employ:
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) to identify genomic binding sites
RNA-seq following FAM204A perturbation to identify regulated genes
ATAC-seq to assess chromatin accessibility changes
Protein-protein interaction studies focusing on known transcriptional regulators
These approaches should be complemented with mechanistic validation experiments such as reporter assays or directed mutagenesis of functional domains.
For comparison, FAM208A (D14Abb1e) was found to interact with H3K9me3, a chromatin mark associated with gene silencing , while FAM20A expression varied during hematopoietic differentiation, suggesting potential regulatory roles in this process .
Comparative analysis of FAM204A across species provides evolutionary context:
Zebrafish fam204a encodes a protein of 234 amino acids, classified in the Protein FAM204A family (IPR037690)
Evolutionary analysis of other FAM protein families shows patterns of gene duplication and diversification
FAM20 family demonstrates expansion from a single gene in simpler organisms (C. elegans) to multiple genes in vertebrates
When conducting comparative studies, researchers should:
Use multiple sequence alignments to identify conserved domains
Consider syntenic relationships when confirming true orthologs
Examine expression patterns across species to identify conserved regulatory mechanisms
Evolutionary analysis of FAM protein families can provide functional insights:
Phylogenetic tree construction to determine relatedness to functionally characterized FAM proteins
Identification of conserved sequence motifs that may indicate shared functional domains
Analysis of selection pressure (dN/dS ratios) across different domains
Correlation of gene duplication events with evolutionary innovations
The expansion observed in the FAM20 family, which evolved through gene duplication events in both vertebrates and invertebrates , suggests similar analyses could provide insights into FAM204A evolution and potential functional specialization.
Optimal purification strategies for recombinant FAM204A should consider:
| Purification Method | Application | Considerations |
|---|---|---|
| Affinity chromatography | Initial capture | Selection of appropriate tag (His, GST, FLAG) |
| Size exclusion | Further purification | Separation from aggregates and contaminants |
| Ion exchange | Charge-based separation | Requires knowledge of isoelectric point |
| Hydrophobic interaction | Alternative method | Useful for separating proteins with similar size |
A typical purification workflow might include:
Expression screening in selected system
Initial affinity purification using tagged construct
Tag removal (if necessary) followed by secondary purification
Quality control analysis (see section 5.2)
Comprehensive quality control for recombinant FAM204A should include:
Purity assessment:
SDS-PAGE with Coomassie or silver staining
Size exclusion chromatography
Mass spectrometry
Identity confirmation:
Western blotting with FAM204A-specific antibodies
Peptide mass fingerprinting
N-terminal sequencing
Structural integrity:
Circular dichroism to assess secondary structure
Thermal shift assays to evaluate stability
Dynamic light scattering to detect aggregation
Functional validation:
Binding assays with known interaction partners (once identified)
Activity assays based on discovered functions
Comparison with native protein where possible
Researchers should establish acceptance criteria for each quality parameter based on the intended experimental application of the recombinant protein.